img

Global Polio Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Polio Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Polio vaccines are vaccines used to prevent poliomyelitis. There are two typesone that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
Polio Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Polio Vaccine market is projected to reach US$ 949.9 million in 2034, increasing from US$ 709.8 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2034. Demand from Public and Private are the major drivers for the industry.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Polio Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Segment by Application


Public
Private

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Polio Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Polio Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Polio Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Polio Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Polio Vaccine introduction, etc. Polio Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Polio Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Polio Vaccine Market Overview
1.1 Polio Vaccine Product Overview
1.2 Polio Vaccine Market Segment by Type
1.2.1 Inactivated Polio Vaccine (IPV)
1.2.2 Oral Polio Vaccine (OPV)
1.3 Global Polio Vaccine Market Size by Type
1.3.1 Global Polio Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Polio Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Polio Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Polio Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Polio Vaccine Sales Breakdown by Type (2018-2024)
2 Global Polio Vaccine Market Competition by Company
2.1 Global Top Players by Polio Vaccine Sales (2018-2024)
2.2 Global Top Players by Polio Vaccine Revenue (2018-2024)
2.3 Global Top Players by Polio Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Polio Vaccine Market Competitive Situation and Trends
2.5.1 Polio Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Polio Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Polio Vaccine Market
2.8 Key Manufacturers Polio Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Polio Vaccine Status and Outlook by Region
3.1 Global Polio Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Polio Vaccine Historic Market Size by Region
3.2.1 Global Polio Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Polio Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Polio Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Polio Vaccine Forecasted Market Size by Region
3.3.1 Global Polio Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Polio Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Polio Vaccine by Application
4.1 Polio Vaccine Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Polio Vaccine Market Size by Application
4.2.1 Global Polio Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Polio Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Polio Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Polio Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Polio Vaccine Sales Breakdown by Application (2018-2024)
5 North America Polio Vaccine by Country
5.1 North America Polio Vaccine Historic Market Size by Country
5.1.1 North America Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Polio Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Polio Vaccine Sales in Value by Country (2018-2024)
5.2 North America Polio Vaccine Forecasted Market Size by Country
5.2.1 North America Polio Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Polio Vaccine Sales in Value by Country (2024-2034)
6 Europe Polio Vaccine by Country
6.1 Europe Polio Vaccine Historic Market Size by Country
6.1.1 Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Polio Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Polio Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Polio Vaccine Forecasted Market Size by Country
6.2.1 Europe Polio Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Polio Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Polio Vaccine by Region
7.1 Asia-Pacific Polio Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Polio Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Polio Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Polio Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Polio Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Polio Vaccine Sales in Value by Region (2024-2034)
8 Latin America Polio Vaccine by Country
8.1 Latin America Polio Vaccine Historic Market Size by Country
8.1.1 Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Polio Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Polio Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Polio Vaccine Forecasted Market Size by Country
8.2.1 Latin America Polio Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Polio Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Polio Vaccine by Country
9.1 Middle East and Africa Polio Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Polio Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Polio Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Polio Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Polio Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Polio Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Polio Vaccine Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Polio Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Bibcol
10.3.1 Bibcol Company Information
10.3.2 Bibcol Introduction and Business Overview
10.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bibcol Polio Vaccine Products Offered
10.3.5 Bibcol Recent Development
10.4 Serum Institute
10.4.1 Serum Institute Company Information
10.4.2 Serum Institute Introduction and Business Overview
10.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Serum Institute Polio Vaccine Products Offered
10.4.5 Serum Institute Recent Development
10.5 Tiantan Biological
10.5.1 Tiantan Biological Company Information
10.5.2 Tiantan Biological Introduction and Business Overview
10.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Tiantan Biological Polio Vaccine Products Offered
10.5.5 Tiantan Biological Recent Development
10.6 IMBCA
10.6.1 IMBCA Company Information
10.6.2 IMBCA Introduction and Business Overview
10.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 IMBCA Polio Vaccine Products Offered
10.6.5 IMBCA Recent Development
10.7 Panacea Biotec Ltd
10.7.1 Panacea Biotec Ltd Company Information
10.7.2 Panacea Biotec Ltd Introduction and Business Overview
10.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Panacea Biotec Ltd Polio Vaccine Products Offered
10.7.5 Panacea Biotec Ltd Recent Development
10.8 Bio-Med
10.8.1 Bio-Med Company Information
10.8.2 Bio-Med Introduction and Business Overview
10.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bio-Med Polio Vaccine Products Offered
10.8.5 Bio-Med Recent Development
10.9 Halfkin Bio-Pharmaceuticals
10.9.1 Halfkin Bio-Pharmaceuticals Company Information
10.9.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Products Offered
10.9.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Polio Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Polio Vaccine Industrial Chain Analysis
11.4 Polio Vaccine Market Dynamics
11.4.1 Polio Vaccine Industry Trends
11.4.2 Polio Vaccine Market Drivers
11.4.3 Polio Vaccine Market Challenges
11.4.4 Polio Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Polio Vaccine Distributors
12.3 Polio Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Inactivated Polio Vaccine (IPV)
Table 2. Major Company of Oral Polio Vaccine (OPV)
Table 3. Global Polio Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Polio Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Polio Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Polio Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Polio Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Polio Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Polio Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Polio Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Polio Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Polio Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Polio Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Polio Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Polio Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Polio Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Polio Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Polio Vaccine Sales Share by Company (2018-2024)
Table 26. Global Polio Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Polio Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Polio Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Polio Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Polio Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Polio Vaccine Market
Table 33. Key Manufacturers Polio Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Polio Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Polio Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Polio Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Polio Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Polio Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Polio Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Polio Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Polio Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Polio Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Polio Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Polio Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Polio Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Polio Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Polio Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Polio Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. Global Polio Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Polio Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Polio Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Polio Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Polio Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Polio Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Polio Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Polio Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Polio Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Polio Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Polio Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Polio Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Polio Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Polio Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Polio Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Polio Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Polio Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Polio Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Polio Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Polio Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Polio Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Polio Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Polio Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Polio Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Polio Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Polio Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Polio Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Polio Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Polio Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Polio Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Sanofi Company Information
Table 108. Sanofi Introduction and Business Overview
Table 109. Sanofi Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Polio Vaccine Product
Table 111. Sanofi Recent Development
Table 112. GSK Company Information
Table 113. GSK Introduction and Business Overview
Table 114. GSK Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. GSK Polio Vaccine Product
Table 116. GSK Recent Development
Table 117. Bibcol Company Information
Table 118. Bibcol Introduction and Business Overview
Table 119. Bibcol Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Bibcol Polio Vaccine Product
Table 121. Bibcol Recent Development
Table 122. Serum Institute Company Information
Table 123. Serum Institute Introduction and Business Overview
Table 124. Serum Institute Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Serum Institute Polio Vaccine Product
Table 126. Serum Institute Recent Development
Table 127. Tiantan Biological Company Information
Table 128. Tiantan Biological Introduction and Business Overview
Table 129. Tiantan Biological Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Tiantan Biological Polio Vaccine Product
Table 131. Tiantan Biological Recent Development
Table 132. IMBCA Company Information
Table 133. IMBCA Introduction and Business Overview
Table 134. IMBCA Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. IMBCA Polio Vaccine Product
Table 136. IMBCA Recent Development
Table 137. Panacea Biotec Ltd Company Information
Table 138. Panacea Biotec Ltd Introduction and Business Overview
Table 139. Panacea Biotec Ltd Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Panacea Biotec Ltd Polio Vaccine Product
Table 141. Panacea Biotec Ltd Recent Development
Table 142. Bio-Med Company Information
Table 143. Bio-Med Introduction and Business Overview
Table 144. Bio-Med Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Bio-Med Polio Vaccine Product
Table 146. Bio-Med Recent Development
Table 147. Halfkin Bio-Pharmaceuticals Company Information
Table 148. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
Table 149. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Halfkin Bio-Pharmaceuticals Polio Vaccine Product
Table 151. Halfkin Bio-Pharmaceuticals Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Polio Vaccine Market Trends
Table 155. Polio Vaccine Market Drivers
Table 156. Polio Vaccine Market Challenges
Table 157. Polio Vaccine Market Restraints
Table 158. Polio Vaccine Distributors List
Table 159. Polio Vaccine Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Polio Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Polio Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 6. Global Inactivated Polio Vaccine (IPV) Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Oral Polio Vaccine (OPV)
Figure 8. Global Oral Polio Vaccine (OPV) Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Polio Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Polio Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Polio Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Polio Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Polio Vaccine Revenue in 2022
Figure 23. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Public
Figure 25. Global Public Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Private
Figure 27. Global Private Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Global Polio Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Polio Vaccine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Polio Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Polio Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Polio Vaccine Manufacturing Cost Structure
Figure 41. Polio Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries